Status and phase
Conditions
Treatments
About
Sixty two subjects will take part in this study. The study is unic arm. The subjects used the product once and will be evaluated in the regression of pimples in the times 0,4,6,8 and 24 hours after application.
A follow-up visit will be made 24 hours after initiation of treatment.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
62 participants in 1 patient group
Loading...
Central trial contact
Sergio Schalka, Doctor's
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal